Full Press Release Details
Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies.
BIIB
Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies
Key Takeaway: Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis